Comac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the growth champions in Europe.
IMP³rove assessment
October 19, 2015
Share:
News
Introduction Central and Eastern Europe (CEE) has become a leading destination for clinical trials, offering a compelling mix...
[Sofia, Bulgaria] — Comac Medical is delighted to announce the appointment of Christian Buhlmann as its new Chief...
Sofia, Bulgaria – 23rd January 2025 Comac Medical is proud to announce that its state-of-the-art laboratory has successfully...